Skip to main navigation Skip to search Skip to main content

Risk factors for prolonged length of stay after the stage 2 procedure in the single-ventricle reconstruction trial

  • Steven M. Schwartz
  • , Minmin Lu
  • , Richard G. Ohye
  • , Kevin D. Hill
  • , Andrew M. Atz
  • , Maryam Y. Naim
  • , Ismee A. Williams
  • , Caren S. Goldberg
  • , Alan Lewis
  • , Frank Pigula
  • , Peter Manning
  • , Christian Pizarro
  • , Paul Chai
  • , Rachel McCandless
  • , Carolyn Dunbar-Masterson
  • , Jonathan R. Kaltman
  • , Kirk Kanter
  • , Lynn A. Sleeper
  • , Julie V. Schonbeck
  • , Nancy Ghanayem
    • University of Toronto
    • New England Research Institutes
    • University of Michigan, Ann Arbor
    • Duke University
    • Medical University of South Carolina
    • The Children's Hospital of Philadelphia
    • Columbia University
    • Children's Hospital Los Angeles
    • Boston Children's Hospital
    • Cincinnati Children's Hospital Medical Center
    • Johns Hopkins University
    • Primary Children's Medical Center
    • National Institutes of Health
    • Emory University
    • Medical College of Wisconsin

    Research output: Contribution to journal › Article › peer-review

    45 Scopus citations

    Abstract

    Background The single-ventricle reconstruction trial randomized patients with single right ventricle lesions to a modified Blalock-Taussig or right ventricle-to-pulmonary artery shunt at the Norwood. This analysis describes outcomes at the stage 2 procedure and factors associated with a longer hospital length of stay (LOS). Methods We examined the association of shunt type with stage 2 hospital outcomes. Cox regression and bootstrapping were used to evaluate risk factors for longer LOS. We also examined characteristics associated with in-hospital death. Results There were 393 subjects in the analytic cohort. Median stage 2 procedure hospital LOS (8 days; interquartile range [IQR], 6-14 days), hospital mortality (4.3%), transplantation (0.8%), median ventilator time (2 days; IQR, 1-3 days), median intensive care unit LOS (4 days; IQR, 3-7 days), number of additional cardiac procedures or complications, and serious adverse events did not differ by shunt type. Longer LOS was associated (R2 = 0.26) with center, longer post-Norwood LOS (hazard ratio [HR], 1.93 per log day; P <.001), nonelective timing of the stage 2 procedure (HR, 1.78; P <.001), and pulmonary artery (PA) stenosis (HR, 1.56; P <.001). By univariate analysis, nonelective stage 2 (65% vs 32%; P =.009), moderate or greater atrioventricular valve (AVV) regurgitation (75% vs 24%; P <.001), and AVV repair (53% vs 9%; P <.001) were among the risk factors associated with in-hospital death. Conclusions Norwood LOS, PA stenoses, and nonelective stage 2 procedure, but not shunt type, are independently associated with longer LOS. Nonelective stage 2 procedure, moderate or greater AVV regurgitation, and need for AVV repair are among the risk factors for death.

    Original languageEnglish
    Pages (from-to)1791-1798.e4
    JournalJournal of Thoracic and Cardiovascular Surgery
    Volume147
    Issue number6
    DOIs
    StatePublished - Jun 2014

    Fingerprint

    Dive into the research topics of 'Risk factors for prolonged length of stay after the stage 2 procedure in the single-ventricle reconstruction trial'. Together they form a unique fingerprint.

    Cite this